October 25, 2018 DURHAM, N.C.--(BUSINESS WIRE)--Bioventus, a global leader in orthobiologic solutions, today announced the appointment of Susan M. Stalnecker, former Vice President and Treasurer, E.I. du Pont de Nemours and Company, to the company’s Board of Managers, replacing Michael Minogue. “Susan is joining the Bioventus Board at an exciting time as we accelerate the growth of our
WAYNE, Pa., Oct. 25, 2018 /PRNewswire/ -- Camber Spine today announced reaching the $1 million milestone with their recently launched SPIRA™-C in less than 6 months. "The remarkable success and the early adoption of this revolutionary technology by so many surgeon users has attributed to this milestone," commented CEO, Daniel Pontecorvo. "Camber Spine is now following through on its promise to be
CARLSBAD, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV:ASG) ("Aurora Spine" or the "Company") announced today the grant by the European Patent Office (the “EPO”) of Aurora’s first European patent related to the ZIP®, minimally invasive spinal implant. The patent is titled “Dynamic and Non-Dynamic Interspinous Fusion Implant and Bone Growth Stimulation
October 25, 2018 HOUSTON--(BUSINESS WIRE)--SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc nucleus using human dermal fibroblasts (HDFs), today announced 12-month endpoint data from its Phase 1/Phase 2 clinical trial for treatment of degenerative disc disease (DDD). The analysis showed that patients who received intradiscal injections of the HDF
October 23, 2018 HUNTLEY, Ill.--(BUSINESS WIRE)--Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that the company recognized an EBITDA growth rate of 124% in the third quarter of 2018 over the third quarter of 2017. This was driven by a sales
October 24, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today reported financial results for the third quarter ended September 30, 2018, and provided an update on its business progress in the period. “Anika delivered solid financial results
October 24, 2018 BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK) (“Anika” or the “Company”), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, announced that, effective immediately, Anika’s Board of Directors has appointed Susan Vogt as an independent director. Ms. Vogt most recently served as Chief Executive
SAN FRANCISCO, October 24, 2018 /PRNewswire/ -- The global ambulatory surgery center market is subject to witness a substantial growth over the forecast period due to the growing geriatric population, rising occurrence of chronic diseases, surging in healthcare costs, and recent technological advancements in the healthcare sector. However, absence of expertise and increase in number of reimbursement issues are
Kalamazoo, Michigan - October 23, 2018 - Stryker (NYSE:SYK) announced today the completion of its previously announced acquisition of Invuity, Inc. Invuity is the leader in advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical applications including orthopaedic and spine surgery, general surgery and women's health procedures, and is a recent
October 23, 2018 AUSTIN, Texas--(BUSINESS WIRE)--DJO (“DJO” or the “Company”), a leading provider of medical technologies designed to get and keep people moving, released a new clinical study to show that EMPOWR 3D Knee technology reduces patient dissatisfaction, and improves function and activity levels. Based on a multitude of studies on the biomechanics and kinematics
